Skip to main content

Table 3 Baseline ORM related to menstrual outcome 6 months after CTX group of anovulatory patients (oligomenorrheic and amenorreic) and group of ovulatory patients (eumenorrheic)

From: Age, anti-müllerian hormone, antral follicles count to predict amenorrhea or oligomenorrhea after chemotherapy with cyclophosphamide

  Eumenorrhea (n = 19) Oligomenorrhea + Amenorrhea (n = 28)
Age (years) 32.9 ± 3.5 36.5 ± 3.8*
AMH (ng/mL) 5.34 (2.71–8.15) 1.31 (0.72 – 2.89)**
AFC (follicles) 13.5 (11–16) 9 (7.75–12)**
  1. Oligomenorrhea + Amenorrhea X Eumenorrhea (Regular cycles): *p = 0.02; **p < 0.001